Maintain TXN at current weight with active patience framework
The debate genuinely balances, and HOLD with explicit tactical triggers is the disciplined synthesis. The aggressive analyst correctly identifies that anchoring on TTM PE 39x is rearview-mirror thinking (forward 24x is more honest given the Q2 print), that the FCF inflection from capex normalization ($1.31B → $514M quarterly) is a hard mechanical driver unlocking an $8.8B annualized run-rate, that ATR contraction from $11 to $8.81 is classic base-building behavior, and that the 200 SMA at $241 represents genuine institutional buying gravity. However, the aggressive analyst's 5:1 reward-to-risk math anchors on the all-time high of $323 and explicitly ignores peer-group weakness signaling real cyclical deterioration. The conservative analyst correctly identifies that the 95% no-cut macro regime compresses multiples for high-multiple cyclicals and that consensus $10.64 forward EPS is vulnerable to revision toward $9.00-9.50 given industrial/auto softness. The decisive tiebreaker: the bull's own thesis requires confirmation triggers ($261 close, $274 reclaim) that have NOT fired, revealing the aggressive analyst doesn't actually believe the asymmetry he claims. The 2.18% dividend yield backed by $4.9B cash and 20+ years of consecutive growth is actual return accruing while waiting. Q3 2026 earnings in late October is the binary catalyst resolving whether forward EPS estimates hold or get revised down.
| Position | Action |
|---|---|
| relief rally into $268-272 (below 50 SMA) | modest 5-10% trim |
| price at $252-258 with declining volume confirmation | add zone |
| daily close above $274 on >5M volume OR constructive Q3 2026 print with reaffirmed guidance | full Overweight upgrade |
| current position | maintain current weight; do not exceed benchmark until confirmation triggers fire |
TXN represents a high-quality cyclical at the start of a recovery, with accelerating revenue, peaking capex, and structural data center growth creating the conditions for the next leg up despite the recent 90-day drawdown.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 261.10 | bearish |
| 50 SMA | 274.26 | bearish |
| 200 SMA | 241.63 | bullish |
| RSI | 43.06 | neutral |
| MACD Line | -3.61 | bullish |
| MACD Signal | -4.66 | neutral |
| MACD Histogram | +1.05 | bullish |
| Bollinger Middle (20 SMA) | 260.55 | neutral |
| Bollinger Upper Band | 268.68 | neutral |
| Bollinger Lower Band | 252.41 | neutral |
| ATR | 8.81 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: confirmed daily close above $274 on >5M volume
Then: upgrade to full Overweight
Capex cycle has decisively turned, creating powerful FCF generation as revenue grows while capex declines
↩ rebuts: “Bear underweighting of capex cycle turn and FCF generation potential”
EV: +17.8% to +19.2% (12-18 month target $330-$340 from current ~$257) · concedes: Would prefer to see daily close back above the 50 SMA at $274 with expanding volume before getting aggressive on adding; Short-term tape is ugly with lower highs and lower lows since May; Bear discipline of waiting for confirmation is respected
TXN is priced for a recovery that may not arrive, trading at a historically rich TTM PE of 39.3x with forward EPS at high risk of downward revision, in a macro regime hostile to high-multiple cyclicals, with a weakening balance sheet and inventory overhang creating asymmetric downside risk to $215-235.
EV: -9% to -17% downside to $215-235 · concedes: Dividend is defensible for income holders; existing holders can stay if yield is primary objective; 300mm fab cost advantage is real, though 'known and priced in for years'; Q2 headline numbers (revenue +22.8%, EPS +52%, gross margin 61.4%) were objectively strong; Data center revenue doubling is a genuine positive, even if base is small; Sentiment score 6.1/10 indicates no crowded-trade risk
→ vs conservative: TTM PE of 39x is a rearview mirror argument already obsolete before next earnings report; Q2's $2.14 EPS annualizes to $8.56 vs $6.57 TTM, collapsing the multiple
→ vs conservative: Symmetric 1:1 risk-reward analysis is mathematically lazy; probability-weighted outcomes strongly favor upside given confirmed Q2 print, FCF inflection, and MACD crossover
→ vs conservative: Confirmation triggers are process worship in fundamentally-driven names; Q2 was the confirmation, not a future chart pattern
→ vs conservative: Waiting for 50 SMA reclaim at $274 means paying 6% more for identical position and risk profile
→ vs conservative: HOLD carries real opportunity cost in asymmetric setup; sitting out while double-engine re-rating (multiple normalization + EPS expansion) plays out is a real decision with real cost
| bullish |
| VWMA | 259.74 | bearish |
Support: 241.63 · 252.41 · 235 | Resistance: 268.68 · 274 · 263 · 264
TXN has pulled back roughly 20% from its May 26, 2026 high of $323.24 to the current close of $258.14, forming a multi-month downtrend with consecutive lower highs and lower lows; however, the price remains above the 200 SMA ($241.63), preserving the long-term uptrend structure. The MACD bullish crossover on September 8 with histogram now positive (+1.05) and ATR contracting from $11.15 to $8.81 suggest base-building rather than a confirmed reversal—the stock needs to reclaim the 10 EMA ($261.10) and VWMA ($259.74) for Trigger A or the 50 SMA ($274.26) for Trigger B to confirm a trend change. Risk management suggests an ATR-based stop near $249 for tactical longs, with $240 (200 SMA) as the critical invalidation level.
Market Cap
$235.7B
PE Ratio (TTM)
39.29×
Forward PE
24.25×
PEG Ratio
0.93
Price / Book
13.09×
EPS (TTM)
$6.57
Forward EPS
$10.64
Dividend Yield
2.18%
Beta
1.31
52-Week High
$334.03
52-Week Low
$152.73
50-Day Avg Price
$275.60
200-Day Avg Price
$242.98
Revenue FY2025
$17,682M
Revenue YoY Growth FY2025
+13.0%
Gross Profit FY2025
$10,083M
Gross Margin FY2025
57.0%
Operating Income FY2025
$6,140M
Operating Margin FY2025
34.7%
Net Income FY2025
$5,001M
Diluted EPS FY2025
$5.45
Revenue Q2 2026
$5,463M
Revenue YoY Q2 2026
+22.8%
Gross Margin Q2 2026
61.4%
Operating Margin Q2 2026
42.6%
Diluted EPS Q2 2026
$2.14
TTM Revenue
$19.5B
TTM Net Income
$6.0B
Gross Margin (TTM)
58.3%
Operating Margin (TTM)
42.6%
Profit Margin (TTM)
31.1%
EBITDA Margin (TTM)
48.9%
ROE
35.2%
ROA
13.1%
Operating Cash Flow FY2025
$7,153M
Capital Expenditure FY2025
-$4,550M
Free Cash Flow FY2025
$2,603M
Dividends Paid FY2025
-$4,999M
TTM FCF
$3.5B
Q2 2026 FCF
$2.19B
Q2 2026 FCF Annualized Run-Rate
$8.8B
Cash & ST Investments FY2025
$4,881M
Inventory FY2025
$4,804M
Net PPE FY2025
$12,320M
Total Assets FY2025
$34,585M
Long-Term Debt FY2025
$13,548M
Net Debt FY2025
$10,823M
Stockholders' Equity FY2025
$16,273M
Current Ratio FY2025
4.86
Debt / Equity
78.0%
Net Debt / Equity
67%
Quarterly Capex Q2 2026
$514M
Annualized Dividend Run-Rate
$5.16B
Revenue FY2024
$15,641M
Revenue FY2023
$17,519M
Revenue FY2022
$20,028M
Gross Margin FY2022
68.8%
Diluted EPS FY2022
$9.41
Strengths
Concerns
Texas Instruments is a foundational analog and embedded processing semiconductor company headquartered in Dallas, Texas, with a fortress balance sheet and a 20+ year dividend growth track record. The company is navigating the early innings of a cyclical recovery following the 2023-2024 semiconductor downcycle, with Q2 2026 demonstrating accelerating revenue growth (+22.8% YoY), expanding gross margins to 61.4%, and a peaking capex cycle ($514M in Q2 2026 vs. $1.31B peak) that should drive free cash flow expansion to an estimated $8.8B annualized run-rate. Valuation is bifurcated — TTM PE of 39.29× is rich on backward-looking earnings, but forward PE of 24.25× and PEG of 0.93 reflect reasonable growth-adjusted valuation, with consensus forward EPS of $10.64 implying ~62% EPS expansion from TTM levels of $6.57.
Macro: The macro backdrop is characterized by a hawkish Fed regime, with prediction markets pricing 95% odds of zero rate cuts in 2026. 10-year Treasury yields are easing per news signals, supportive for growth/tech multiples. Oil declined to approximately $100/barrel, reducing input-cost pressure on industrial and consumer end markets. The US-China tariff agreement is priced at 89% probability by year-end, suggesting supply-chain relief. Recession tail risk is low at 10% but rising (+2pp WoW). The overall macro environment presents a headwind for re-rating high-quality cyclicals like TXN that have rallied ~47% YTD, but is not a thesis-breaker given the lack of fundamental deterioration.